Cargando…
Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts
BACKGROUND: Small airway narrowing is an important pathology which impacts lung function in chronic obstructive pulmonary disease (COPD). The accumulation of fibroblasts and myofibroblasts contribute to inflammation, remodeling and fibrosis by production and release of mediators such as cytokines, p...
Autores principales: | Tannheimer, Stacey L, Wright, Clifford D, Salmon, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342220/ https://www.ncbi.nlm.nih.gov/pubmed/22452977 http://dx.doi.org/10.1186/1465-9921-13-28 |
Ejemplares similares
-
Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010) -
Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
por: Raschi, Elena, et al.
Publicado: (2018) -
Inhibition of profibrotic microRNA-21 affects platelets and their releasate
por: Barwari, Temo, et al.
Publicado: (2018) -
Mechanical regulation of cardiac fibroblast profibrotic phenotypes
por: Herum, Kate M., et al.
Publicado: (2017) -
Transforming Growth Factor Beta 1 Stimulates Profibrotic Activities of Luteal Fibroblasts in Cows(1)
por: Maroni, Dulce, et al.
Publicado: (2012)